These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 23281407)

  • 41. Oxidized low-density lipoprotein biomarkers in atherosclerosis.
    Tsimikas S
    Curr Atheroscler Rep; 2006 Jan; 8(1):55-61. PubMed ID: 16455015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation and immunity in diabetic vascular complications.
    Nilsson J; Bengtsson E; Fredrikson GN; Björkbacka H
    Curr Opin Lipidol; 2008 Oct; 19(5):519-24. PubMed ID: 18769234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmunity, infectious immunity, and atherosclerosis.
    Matsuura E; Kobayashi K; Matsunami Y; Shen L; Quan N; Makarova M; Suchkov SV; Ayada K; Oguma K; Lopez LR
    J Clin Immunol; 2009 Nov; 29(6):714-21. PubMed ID: 19795194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
    Nilsson J; Nordin Fredrikson G; Schiopu A; Shah PK; Jansson B; Carlsson R
    Curr Pharm Des; 2007; 13(10):1021-30. PubMed ID: 17430165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis.
    Leibundgut G; Witztum JL; Tsimikas S
    Curr Opin Pharmacol; 2013 Apr; 13(2):168-79. PubMed ID: 23541680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formation of atherosclerotic lesions is independent of eosinophils in male mice.
    Hofheinz K; Seibert F; Ackermann JA; Dietel B; Tauchi M; Oszvar-Kozma M; Kühn H; Schett G; Binder CJ; Krönke G
    Atherosclerosis; 2020 Oct; 311():67-72. PubMed ID: 32947200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory reactions in the pathogenesis of atherosclerosis.
    Fan J; Watanabe T
    J Atheroscler Thromb; 2003; 10(2):63-71. PubMed ID: 12740479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall.
    Ketelhuth DF; Hansson GK
    Thromb Haemost; 2011 Nov; 106(5):779-86. PubMed ID: 21979058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidized-LDL immunization for the treatment of atherosclerosis: how far are we?
    Papageorgiou N; Tousoulis D
    Int J Cardiol; 2016 Nov; 222():93-94. PubMed ID: 27479549
    [No Abstract]   [Full Text] [Related]  

  • 50. New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.
    Wu MY; Li CJ; Hou MF; Chu PY
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide 19 of Porphyromonas gingivalis Heat Shock Protein Is a Potent Inducer of Low-Density Lipoprotein Oxidation.
    Joo JY; Cha GS; Chung J; Lee JY; Kim SJ; Choi J
    J Periodontol; 2017 Feb; 88(2):e58-e64. PubMed ID: 27712463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity.
    Roy P; Orecchioni M; Ley K
    Nat Rev Immunol; 2022 Apr; 22(4):251-265. PubMed ID: 34389841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammation and atherosclerosis.
    Kaperonis EA; Liapis CD; Kakisis JD; Dimitroulis D; Papavassiliou VG
    Eur J Vasc Endovasc Surg; 2006 Apr; 31(4):386-93. PubMed ID: 16359887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Atherogenesis in human - clinical aspects of circulating immune complexes].
    Babintseva YD; Sergeeva AM; Karagodin VP; Orekhov AN
    Klin Med (Mosk); 2016; 94(5):325-32. PubMed ID: 30289642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of modification of lipoproteins and of the immune system in early atherogenesis.
    Mol MJ; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Aug; 43(1-2):83-90. PubMed ID: 8232700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
    Miller YI; Choi SH; Wiesner P; Fang L; Harkewicz R; Hartvigsen K; Boullier A; Gonen A; Diehl CJ; Que X; Montano E; Shaw PX; Tsimikas S; Binder CJ; Witztum JL
    Circ Res; 2011 Jan; 108(2):235-48. PubMed ID: 21252151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid-driven immunometabolic responses in atherosclerosis.
    Gisterå A; Ketelhuth DFJ
    Curr Opin Lipidol; 2018 Oct; 29(5):375-380. PubMed ID: 30156570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptive immunity and atherosclerosis.
    Andersson J; Libby P; Hansson GK
    Clin Immunol; 2010 Jan; 134(1):33-46. PubMed ID: 19635683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.